• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AV-TEMECULA-CT ABSORB BIORESORBABLE VASCULAR SCAFFOLD SYSTEM; BIORESORBABLE DRUG ELUTING SCAFFOLD

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AV-TEMECULA-CT ABSORB BIORESORBABLE VASCULAR SCAFFOLD SYSTEM; BIORESORBABLE DRUG ELUTING SCAFFOLD Back to Search Results
Device Problem Patient-Device Incompatibility (2682)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 12/02/2018
Event Type  malfunction  
Manufacturer Narrative
(b)(4).During processing of this complaint, attempts were made to obtain complete event, patient and device information.Literature attachment: the demise of the absorb bvs: lessons learned from the discontinuation of a disappearing stent.Date of event has been estimated.Date of implant has been estimated.The scaffold remains in the patient.Investigation is not yet complete.A follow up report will be submitted with all additional relevant information.The additional adverse patient effects referenced in the article are being filed under a separate medwatch report #.
 
Event Description
It was identified through review of the article that the absorb bioresorbable vascular scaffold (bvs) may be related to under-expansion and mal-apposition of the scaffold.It is unknown what intervention was performed, if any.Details are listed in the article, titled, "the demise of the absorb bvs: lessons learned from the discontinuation of a disappearing stent".
 
Manufacturer Narrative
Internal file number - (b)(4).The device was not returned for evaluation.A review of the lot history record and complaint history of the reported lot could not be conducted because the part and lot numbers were not provided.Based on the information reviewed, a conclusive cause for the reported difficulty to deploy could not be determined.There is no indication of a product quality issue with respect to manufacture, design or labeling.Unique device identifier (udi): in the absence of reported part number, udi cannot be calculated.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ABSORB BIORESORBABLE VASCULAR SCAFFOLD SYSTEM
Type of Device
BIORESORBABLE DRUG ELUTING SCAFFOLD
Manufacturer (Section D)
AV-TEMECULA-CT
abbott vascular
26531 ynez road
temecula CA 92591 4628
MDR Report Key8297628
MDR Text Key134860869
Report Number2024168-2019-00761
Device Sequence Number1
Product Code PNY
Combination Product (y/n)N
PMA/PMN Number
P150023
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type literature
Remedial Action Other
Type of Report Initial,Followup
Report Date 02/15/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 01/07/2019
Initial Date FDA Received02/01/2019
Supplement Dates Manufacturer Received02/11/2019
Supplement Dates FDA Received02/15/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-